Medical College of Wisconsin (MD) Medicine InterviewFormat, Questions & Prep Tips

Why MCW? What specifically draws you to a private independent research medical school in Milwaukee?

Reference the NIH research programmes (genomics, cardiovascular, cancer), Froedtert's clinical breadth, Milwaukee's diverse patient population and health equity challenges, and the school's national applicant pool and independent identity. Avoid generic "great research" responses.

Walk me through your most significant research experience. What was the scientific question, what did you find, and what would you pursue next?

MCW is a top-20 NIH-funded institution — research depth matters. Show intellectual ownership and continuity of curiosity. Interviewers may probe methodology, statistical reasoning, and the significance of your findings within the broader field.

Milwaukee has one of the highest rates of racial health disparities in the Midwest. You are working in a community health centre in a predominantly Black neighbourhood. A patient expresses distrust of the healthcare system. How do you build trust?

Acknowledge the historical and contemporary basis for medical distrust in Black communities (Tuskegee, recent COVID disparities, documented pain management biases). Practise cultural humility, ask before assuming, and avoid a defensive "not all doctors" response. Building trust is a sustained process, not a single appointment.

A genomic sequencing result reveals an incidental finding of a pathogenic BRCA1 variant in a patient who consented only to cardiac risk testing. What are your obligations?

Address the duty to disclose incidental findings, the ACMG (American College of Medical Genetics) secondary findings policy, the scope of the original consent, the patient's right not to know, and the psychological and insurance implications of disclosure. Show nuanced understanding of genomic medicine ethics.

A patient who is a recent Hmong immigrant is reluctant to undergo a recommended biopsy. Through your interpreter, you understand she fears that the biopsy will "release the illness" according to her beliefs. How do you proceed?

Apply cultural humility and cross-cultural communication principles. Explore her belief system respectfully, explain what a biopsy actually involves, involve a cultural liaison or community health worker, and ultimately centre patient autonomy — informed refusal is her right.

MCW has made significant contributions to genomic medicine research. What ethical issues does widespread genomic testing in clinical settings raise?

Reference: genetic privacy (GINA protections and their limits), incidental findings obligations, insurance discrimination, direct-to-consumer testing limitations, disparities in genomic databases (underrepresentation of non-European ancestry), and informed consent complexity for patients with limited genomic literacy.

You observe that an attending physician regularly dismisses the pain reports of Black patients more quickly than those of White patients with similar presentations. You have now seen this pattern three times. What do you do?

Implicit bias and structural racism in clinical care. Address the documentation of the pattern, the process for raising concerns (patient safety reporting, implicit bias training programmes), the professional obligation not to remain silent on quality-of-care issues, and the challenge of doing so as a student without alienating your supervisor.

Tell me about an experience that revealed the limits of what medicine can do. How did it change your understanding of your role as a future physician?

Shows intellectual humility and realism. Strong answers acknowledge the social determinants of health as the dominant driver of outcomes, and reframe the physician's role as one node in a broader health ecosystem rather than the sole determinant of patient wellbeing.

A colleague confidentially tells you that she made a medication error that affected a patient but the patient appears to have recovered without harm. The attending physician does not know. What do you advise?

Medical error disclosure is both an ethical obligation and increasingly a legal one (many states have disclosure laws). Address the duty to disclose to the patient and the care team, incident reporting mechanisms, the psychological burden of error on providers (second-victim syndrome), and the difference between punitive and learning cultures in medicine.

Should AI diagnostic tools be allowed to make treatment recommendations without physician oversight in resource-limited settings? Take a position.

Reference AI diagnostic accuracy data for specific tasks (dermatology, radiology, diabetic retinopathy screening), the risk of algorithmic bias in underrepresented populations, the accountability gap when AI is wrong, and the practical argument for supervised AI in resource-limited settings. MCW has biomedical informatics strengths — show awareness of this research area.

Role-play: I am a Black patient at a Milwaukee community health centre. You have recommended a procedure, and I have just told you, warily, that I do not really trust doctors after how my family has been treated. The assessor will play the patient — respond to me.

Acknowledge the legitimacy of the distrust without defensiveness or a 'not all doctors' rebuttal. Ask what would help them feel safer, be transparent about your reasoning, and treat trust-building as a process rather than a single conversation. MCW's traditional interview can include situational prompts; Milwaukee's health-equity context makes this central.

You are shown data showing Milwaukee has one of the largest Black–White gaps in infant mortality among major US cities. What does this disparity reflect, and what would you want to investigate to design an intervention?

Frame the gap as driven by structural and social determinants — segregation, prenatal-care access, chronic stress, insurance — not biology. Discuss prematurity, maternal comorbidities, and what additional data (prenatal-visit timing, neighbourhood-level factors) you would gather. MCW's health-equity emphasis makes disparities literacy essential.

MCW is a leader in genomic medicine and was among the first to use whole-genome sequencing to diagnose a child's rare disease. As genomic sequencing becomes routine, what is the biggest unsolved challenge for using it equitably?

Discuss the underrepresentation of non-European ancestry in genomic reference databases and how it degrades variant interpretation for many patients, alongside access, cost, and genomic-literacy gaps. Connect to MCW's research leadership while showing awareness of equity, not just technical promise.

A clinical AI tool deployed at your hospital was trained mostly on data from White, insured patients and performs worse for the diverse Milwaukee population it now serves. The hospital is reluctant to pause a costly system. What do you do?

Address algorithmic bias, the duty to patient safety and equity, the process for surfacing performance concerns, and the tension with institutional investment. MCW's biomedical-informatics strengths make AI-equity scenarios fair game; show you can weigh evidence and take a principled stance.

You must explain an incidental genomic finding — a pathogenic variant unrelated to the original test — to a patient with limited familiarity with genetics. How do you approach the conversation?

Assess what the patient wants to know, use plain language and analogies, explain implications for them and possibly relatives, address insurance and privacy concerns (GINA and its limits), and support an informed decision about next steps. Genomic-medicine communication is a distinctive MCW competency.